secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001193125-25-331151
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight enters CFO transition agreement with Thunen; reaffirms 2025 outlook
---------------------------------------------------------------------------

- Shelley Thunen transitions from CFO; transition and consulting agreements executed effective Dec 23, 2025.
- Company reaffirms full-year 2025 outlook unchanged by CFO transition.
- Transition was previously announced; material terms incorporated by reference from Dec 22, 2025 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312525331151/0001193125-25-331151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312525331151/rxst-20251223.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-331151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer